Cargando…

Conditional knockout of brca1/2 and p53 in mouse ovarian surface epithelium: Do they play a role in ovarian carcinogenesis?

Alterations of genes are known to be critical for the induction of tumorigenesis, but the mechanism of ovarian carcinogenesis is little understood and remains to be elucidated. In this study, we investigated the roles of brca1, brca2 and p53 genes in the development of ovarian cancer using condition...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Ki-Yon, Park, Dong Wook, Jeung, Eui-Bae, Choi, Kyung-Chul
Formato:	Texto
Lenguaje:	English
Publicado:	The Korean Society of Veterinary Science 2010
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2998739/ https://www.ncbi.nlm.nih.gov/pubmed/21113097 http://dx.doi.org/10.4142/jvs.2010.11.4.291

Ejemplares similares

Induction of Ovarian Leiomyosarcomas in Mice by Conditional Inactivation of Brca1 and p53
por: Quinn, Bridget A., et al.
Publicado: (2009)

Biological Significance of Calbindin-D(9k) within Duodenal Epithelium
por: Hong, Eui-Ju, et al.
Publicado: (2013)

Parabens Accelerate Ovarian Dysfunction in a 4-Vinylcyclohexene Diepoxide-Induced Ovarian Failure Model
por: Lee, Jae-Hwan, et al.
Publicado: (2017)

Primary ex-vivo cultures of human fallopian tube epithelium as a model for serous ovarian carcinogenesis
por: Levanon, Keren, et al.
Publicado: (2009)

Mitogen-activated protein kinases in normal and (pre)neoplastic ovarian surface epithelium
por: Choi, Kyung-Chul, et al.
Publicado: (2003)

Differential epithelial and stromal LGR5 expression in ovarian carcinogenesis
por: Kim, Hyesung, et al.
Publicado: (2022)

Lesser-Known Molecules in Ovarian Carcinogenesis
por: Lozneanu, Ludmila, et al.
Publicado: (2015)

Combined Tumor-Based BRCA1/2 and TP53 Mutation Testing in Ovarian Cancer
por: Borcoman, Edith, et al.
Publicado: (2023)

The BRCA Gene in Epithelial Ovarian Cancer
por: Sánchez-Lorenzo, Luisa, et al.
Publicado: (2022)

Characterization of BRCA Deficiency in Ovarian Cancer
por: Barbero, Giovanna, et al.
Publicado: (2023)

Functional Analysis of Familial Asp67Glu and Thr1051Ser BRCA1 Mutations in Breast/Ovarian Carcinogenesis
por: Pongsavee, Malinee, et al.
Publicado: (2009)

The Establishment of Esophageal Precancerous Lesion Model by Using p53 Conditional Knockout Mouse in Esophageal Epithelium
por: Zhu, Lili, et al.
Publicado: (2020)

Intron variants of the p53 gene are associated with increased risk for ovarian cancer but not in carriers of BRCA1 or BRCA2 germline mutations
por: Wang-Gohrke, S, et al.
Publicado: (1999)

BRCA1/2 Mutation Types Do Not Affect Prognosis in Ovarian Cancer Patients
por: Liontos, Michalis, et al.
Publicado: (2021)

Ovarian surface epithelium: family history and early events in ovarian cancer
por: Wong, Alice ST, et al.
Publicado: (2003)

The p53 heterozygous knockout mouse as a model for chemical carcinogenesis in vascular tissue.
por: Carmichael, N G, et al.
Publicado: (2000)

BRCA immunohistochemistry for screening of BRCA mutation in epithelial ovarian cancer patients
por: Manchana, Tarinee, et al.
Publicado: (2020)

The Impact of BRCA1- and BRCA2 Mutations on Ovarian Reserve Status
por: C.E, Drechsel Katja, et al.
Publicado: (2022)

P53 mutations in breast and ovarian carcinomas from BRCA1 and 2 mutation carriers and noncarriers
por: Sensi, E, et al.
Publicado: (2000)

Spectrum of TP53 Mutations in BRCA1/2 Associated High-Grade Serous Ovarian Cancer
por: Boyarskikh, Ulyana A., et al.
Publicado: (2020)

Overexpression of TMEM158 contributes to ovarian carcinogenesis
por: Cheng, Zhongping, et al.
Publicado: (2015)

Chemical carcinogenesis in the tracheobronchial epithelium.
por: Trump, B F, et al.
Publicado: (1984)

Conditional Inactivation of p53 in Mouse Ovarian Surface Epithelium Does Not Alter MIS Driven Smad2-Dominant Negative Epithelium-Lined Inclusion Cysts or Teratomas
por: Quartuccio, Suzanne M., et al.
Publicado: (2013)

BRCA mutations in the manifestation and treatment of ovarian cancer
por: Pan, Zimin, et al.
Publicado: (2017)

Phase 1 trial of olaparib and oral cyclophosphamide in BRCA breast cancer, recurrent BRCA ovarian cancer, non-BRCA triple-negative breast cancer, and non-BRCA ovarian cancer
por: Lee, Chee Khoon, et al.
Publicado: (2019)

Transcriptional heterogeneity of stemness phenotypes in the ovarian epithelium
por: Carter, Lauren E., et al.
Publicado: (2021)

Transcriptome Patterns of BRCA1- and BRCA2- Mutated Breast and Ovarian Cancers
por: Arakelyan, Arsen, et al.
Publicado: (2021)

Avian WNT4 in the Female Reproductive Tracts: Potential Role of Oviduct Development and Ovarian Carcinogenesis
por: Lim, Chul-Hong, et al.
Publicado: (2013)

Mutational Analysis of BRCA1 Gene in Ovarian and Breast‐ovarian Cancer Families in Japan
por: Takano, Masashi, et al.
Publicado: (1997)

Effects of coenzyme Q10 on ovarian surface epithelium-derived ovarian stem cells and ovarian function in a 4-vinylcyclohexene diepoxide-induced murine model of ovarian failure
por: Lee, Hyun Joo, et al.
Publicado: (2021)

Identifying sequence variants contributing to hereditary breast and ovarian cancer in BRCA1 and BRCA2 negative breast and ovarian cancer patients
por: Jarhelle, Elisabeth, et al.
Publicado: (2019)

CD133 Act as an Essential Marker in Ovarian Carcinogenesis
por: Ikram, Dzul, et al.
Publicado: (2021)

Regulatory T Cells in Ovarian Carcinogenesis and Future Therapeutic Opportunities
por: Cassar, Emily, et al.
Publicado: (2022)

The role of OIP5 in the carcinogenesis and progression of ovarian cancer
por: Zhang, Xin, et al.
Publicado: (2023)

Do Alterations in Mitochondrial DNA Play a Role in Breast Carcinogenesis?
por: Rohan, Thomas E., et al.
Publicado: (2010)

Comparison of HE4, CA125, and Risk of Ovarian Malignancy Algorithm in the Prediction of Ovarian Cancer in Korean Women
por: Cho, Hye Yon, et al.
Publicado: (2015)

Do BRCA1 and BRCA2 gene mutation carriers have a reduced ovarian reserve? Protocol for a prospective observational study
por: Winship, Amy Louise, et al.
Publicado: (2019)

BRCA and Early Events in the Development of Serous Ovarian Cancer
por: George, Sophia H. L., et al.
Publicado: (2014)

BRCA1 founder mutations and ovarian cancer in Belarus
por: Savanevich, A, et al.
Publicado: (2015)

UK BRCA mutation testing in patients with ovarian cancer
por: George, Angela
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_5v9tcufr46ldp19e5q6dbvg856